Neurology
1 drug is in development for Parkinson Disease.
- Companies
- 1
- Clinical trials
- 55
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Parkinson Disease pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| gt-02287 | Gain Therapeutics, Inc. (GANX) |
About this indication
Parkinson Disease context
Neurology·MeSH: Parkinson Disease (D010300)
Also known as: Idiopathic Parkinson Disease, Idiopathic Parkinson's Disease, Lewy Body Parkinson Disease, Lewy Body Parkinson's Disease, Paralysis Agitans, Parkinson's Disease, Parkinsonism, Primary
Prevalence
150.0 / 100K
Incidence
15.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Parkinson Disease?
BioSniper tracks 1 drug in development for Parkinson Disease across 1 company.
How many clinical trials target Parkinson Disease?
There are 55 clinical trials targeting Parkinson Disease tracked by BioSniper.
What is the prevalence of Parkinson Disease?
The estimated prevalence of Parkinson Disease is approximately 150.0 per 100,000 population.